
Large molecule bioanalysis is defined as a type of analytical chemistry which involves effective drug products in combating a variety of chronic disease indications.
Highlights
The global Large Molecule Bioanalytical Testing Service market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Large Molecule Bioanalytical Testing Service is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Large Molecule Bioanalytical Testing Service is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Large Molecule Bioanalytical Testing Service in SMEs is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Large Molecule Bioanalytical Testing Service include Covance, Inc.(LabCorp), IQVIA, Syneos Health, SGS S.A., Toxikon Corporation, Intertek Group plc, Pace Analytical Services LLC(LAB Holding, LLC), Charles River Laboratories. and ICON plc, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Large Molecule Bioanalytical Testing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Large Molecule Bioanalytical Testing Service.
The Large Molecule Bioanalytical Testing Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Large Molecule Bioanalytical Testing Service market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Large Molecule Bioanalytical Testing Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Covance, Inc.(LabCorp)
IQVIA
Syneos Health
SGS S.A.
Toxikon Corporation
Intertek Group plc
Pace Analytical Services LLC(LAB Holding, LLC)
Charles River Laboratories.
ICON plc
PPD Inc.
Segment by Type
Preclinical
With Antibody
Without Antibody
Clinical
Segment by Application
SMEs
Large Firms
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Large Molecule Bioanalytical Testing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Large Molecule Bioanalytical Testing Service Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Preclinical
1.2.3 With Antibody
1.2.4 Without Antibody
1.2.5 Clinical
1.3 Market by Application
1.3.1 Global Large Molecule Bioanalytical Testing Service Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 SMEs
1.3.3 Large Firms
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Large Molecule Bioanalytical Testing Service Market Perspective (2018-2029)
2.2 Large Molecule Bioanalytical Testing Service Growth Trends by Region
2.2.1 Global Large Molecule Bioanalytical Testing Service Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Large Molecule Bioanalytical Testing Service Historic Market Size by Region (2018-2023)
2.2.3 Large Molecule Bioanalytical Testing Service Forecasted Market Size by Region (2024-2029)
2.3 Large Molecule Bioanalytical Testing Service Market Dynamics
2.3.1 Large Molecule Bioanalytical Testing Service Industry Trends
2.3.2 Large Molecule Bioanalytical Testing Service Market Drivers
2.3.3 Large Molecule Bioanalytical Testing Service Market Challenges
2.3.4 Large Molecule Bioanalytical Testing Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Large Molecule Bioanalytical Testing Service Players by Revenue
3.1.1 Global Top Large Molecule Bioanalytical Testing Service Players by Revenue (2018-2023)
3.1.2 Global Large Molecule Bioanalytical Testing Service Revenue Market Share by Players (2018-2023)
3.2 Global Large Molecule Bioanalytical Testing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Large Molecule Bioanalytical Testing Service Revenue
3.4 Global Large Molecule Bioanalytical Testing Service Market Concentration Ratio
3.4.1 Global Large Molecule Bioanalytical Testing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Large Molecule Bioanalytical Testing Service Revenue in 2022
3.5 Large Molecule Bioanalytical Testing Service Key Players Head office and Area Served
3.6 Key Players Large Molecule Bioanalytical Testing Service Product Solution and Service
3.7 Date of Enter into Large Molecule Bioanalytical Testing Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Large Molecule Bioanalytical Testing Service Breakdown Data by Type
4.1 Global Large Molecule Bioanalytical Testing Service Historic Market Size by Type (2018-2023)
4.2 Global Large Molecule Bioanalytical Testing Service Forecasted Market Size by Type (2024-2029)
5 Large Molecule Bioanalytical Testing Service Breakdown Data by Application
5.1 Global Large Molecule Bioanalytical Testing Service Historic Market Size by Application (2018-2023)
5.2 Global Large Molecule Bioanalytical Testing Service Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Large Molecule Bioanalytical Testing Service Market Size (2018-2029)
6.2 North America Large Molecule Bioanalytical Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Large Molecule Bioanalytical Testing Service Market Size by Country (2018-2023)
6.4 North America Large Molecule Bioanalytical Testing Service Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Large Molecule Bioanalytical Testing Service Market Size (2018-2029)
7.2 Europe Large Molecule Bioanalytical Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Large Molecule Bioanalytical Testing Service Market Size by Country (2018-2023)
7.4 Europe Large Molecule Bioanalytical Testing Service Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Large Molecule Bioanalytical Testing Service Market Size (2018-2029)
8.2 Asia-Pacific Large Molecule Bioanalytical Testing Service Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Large Molecule Bioanalytical Testing Service Market Size by Region (2018-2023)
8.4 Asia-Pacific Large Molecule Bioanalytical Testing Service Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Large Molecule Bioanalytical Testing Service Market Size (2018-2029)
9.2 Latin America Large Molecule Bioanalytical Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Large Molecule Bioanalytical Testing Service Market Size by Country (2018-2023)
9.4 Latin America Large Molecule Bioanalytical Testing Service Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Large Molecule Bioanalytical Testing Service Market Size (2018-2029)
10.2 Middle East & Africa Large Molecule Bioanalytical Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Large Molecule Bioanalytical Testing Service Market Size by Country (2018-2023)
10.4 Middle East & Africa Large Molecule Bioanalytical Testing Service Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Covance, Inc.(LabCorp)
11.1.1 Covance, Inc.(LabCorp) Company Detail
11.1.2 Covance, Inc.(LabCorp) Business Overview
11.1.3 Covance, Inc.(LabCorp) Large Molecule Bioanalytical Testing Service Introduction
11.1.4 Covance, Inc.(LabCorp) Revenue in Large Molecule Bioanalytical Testing Service Business (2018-2023)
11.1.5 Covance, Inc.(LabCorp) Recent Development
11.2 IQVIA
11.2.1 IQVIA Company Detail
11.2.2 IQVIA Business Overview
11.2.3 IQVIA Large Molecule Bioanalytical Testing Service Introduction
11.2.4 IQVIA Revenue in Large Molecule Bioanalytical Testing Service Business (2018-2023)
11.2.5 IQVIA Recent Development
11.3 Syneos Health
11.3.1 Syneos Health Company Detail
11.3.2 Syneos Health Business Overview
11.3.3 Syneos Health Large Molecule Bioanalytical Testing Service Introduction
11.3.4 Syneos Health Revenue in Large Molecule Bioanalytical Testing Service Business (2018-2023)
11.3.5 Syneos Health Recent Development
11.4 SGS S.A.
11.4.1 SGS S.A. Company Detail
11.4.2 SGS S.A. Business Overview
11.4.3 SGS S.A. Large Molecule Bioanalytical Testing Service Introduction
11.4.4 SGS S.A. Revenue in Large Molecule Bioanalytical Testing Service Business (2018-2023)
11.4.5 SGS S.A. Recent Development
11.5 Toxikon Corporation
11.5.1 Toxikon Corporation Company Detail
11.5.2 Toxikon Corporation Business Overview
11.5.3 Toxikon Corporation Large Molecule Bioanalytical Testing Service Introduction
11.5.4 Toxikon Corporation Revenue in Large Molecule Bioanalytical Testing Service Business (2018-2023)
11.5.5 Toxikon Corporation Recent Development
11.6 Intertek Group plc
11.6.1 Intertek Group plc Company Detail
11.6.2 Intertek Group plc Business Overview
11.6.3 Intertek Group plc Large Molecule Bioanalytical Testing Service Introduction
11.6.4 Intertek Group plc Revenue in Large Molecule Bioanalytical Testing Service Business (2018-2023)
11.6.5 Intertek Group plc Recent Development
11.7 Pace Analytical Services LLC(LAB Holding, LLC)
11.7.1 Pace Analytical Services LLC(LAB Holding, LLC) Company Detail
11.7.2 Pace Analytical Services LLC(LAB Holding, LLC) Business Overview
11.7.3 Pace Analytical Services LLC(LAB Holding, LLC) Large Molecule Bioanalytical Testing Service Introduction
11.7.4 Pace Analytical Services LLC(LAB Holding, LLC) Revenue in Large Molecule Bioanalytical Testing Service Business (2018-2023)
11.7.5 Pace Analytical Services LLC(LAB Holding, LLC) Recent Development
11.8 Charles River Laboratories.
11.8.1 Charles River Laboratories. Company Detail
11.8.2 Charles River Laboratories. Business Overview
11.8.3 Charles River Laboratories. Large Molecule Bioanalytical Testing Service Introduction
11.8.4 Charles River Laboratories. Revenue in Large Molecule Bioanalytical Testing Service Business (2018-2023)
11.8.5 Charles River Laboratories. Recent Development
11.9 ICON plc
11.9.1 ICON plc Company Detail
11.9.2 ICON plc Business Overview
11.9.3 ICON plc Large Molecule Bioanalytical Testing Service Introduction
11.9.4 ICON plc Revenue in Large Molecule Bioanalytical Testing Service Business (2018-2023)
11.9.5 ICON plc Recent Development
11.10 PPD Inc.
11.10.1 PPD Inc. Company Detail
11.10.2 PPD Inc. Business Overview
11.10.3 PPD Inc. Large Molecule Bioanalytical Testing Service Introduction
11.10.4 PPD Inc. Revenue in Large Molecule Bioanalytical Testing Service Business (2018-2023)
11.10.5 PPD Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Covance, Inc.(LabCorp)
IQVIA
Syneos Health
SGS S.A.
Toxikon Corporation
Intertek Group plc
Pace Analytical Services LLC(LAB Holding, LLC)
Charles River Laboratories.
ICON plc
PPD Inc.
Ìý
Ìý
*If Applicable.
